English
Bulgarian
Chinese (Simplified)
Croatian
Czech
Danish
Dutch
Finnish
French
German
Greek
Hebrew
Hindi
Indonesian
Italian
Japanese
Korean
Macedonian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swedish
Thai
Turkish
Vietnamese
How I treat chronic myeloid leukemia in children and adolescents (Hijiya N et al. Blood, March 2019)
How I treat chronic myeloid leukemia in children and adolescents
Blood, March 2019 (epub ahead of print)
Hijiya N et al.
Discontinuation of imatinib in children with chronic myeloid leukaemia in sustained deep molecular remission: results of the STOP IMAPED study (de Bruin CMA et al. Br J Hematol, March 2019)
Discontinuation of imatinib in children with chronic myeloid leukaemia in sustained deep molecular remission: results of the STOP IMAPED Study
Br J Hematol, March 2019 (epub ahead of print)
de Bruijn CMA et al.
Pediatric chronic myeloid leukemia presenting with extreme thrombocytosis simulating essential thrombocythemia (Boklan JL et al. J Pediatr Hematol Oncol, April 2018)
J Pediatr Hematol Oncol, April 2018
Boklan JL et al.
Dasatinib: A review in pediatric chronic myeloid leukemia (McCafferty EH et al. Paediatric Drugs, November 2018)
Paediatric Drugs, November 2018 (epub ahead of print)
McCafferty EH et al.
Early response does not predict outcome in children and adolescents with chronic myeloid leukemia treated with high-dose imatinib (Giona F et al. Br J Hematol, March 2018) (2)
Br J Hematol, March 2018
Giona F. et al
